BioSpace News Archive

Final Phase IIb Interferon-Free Hepatitis C Data From Boehringer Ingelheim Corporation to be Presented at AASLD

October 2, 2012
·
1 min read
Drug Development

ChemoCentryx, Inc. Reports Data for CCX872, the Company’s Orally Bioavailable, Next-Generation CCR2 Inhibitor, in a Preclinical Model of Diabetic Nephropathy

October 2, 2012
·
1 min read
Business

Thermo Fisher Scientific and bioMerieux, Inc. Renew Partnership for Improved Detection of Sepsis Using PCT Biomarker

October 2, 2012
·
1 min read
Biotech Bay

VIVUS, Inc. Announces 2012 Medical Societal Meeting Schedule for Qsymia (Phentermine and Topiramate Extended-Release) CIV

October 2, 2012
·
1 min read
Drug Development

Varian Medical Systems Release; Journal Highlights National Cancer Institute-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer

October 2, 2012
·
4 min read
BioMidwest

Biomet Inc. Announces Early Tender Offer Results and Acceptance of its 10% Senior Notes Due 2017 (CUSIP Nos. 090613AC4; 550785AA7; U55004AA0) and 11?% Senior Subordinated Notes due 2017 (CUSIP Nos. 090613AE0; 550785AE9; U55004AC6)

October 2, 2012
·
1 min read
Rainbow BioSciences, LLC: Parkinson’s Costs Expected to Rise

October 2, 2012
·
1 min read
Business

Life Technologies Names Senior Vice President of External Affairs & Corporate Communications

October 2, 2012
·
3 min read
Policy

BayBio (Bay Area Bioscience Association) and BIOCOM Commend Passage of AB 1277 to Reduce Redundant Facilities Inspections for Life Science Companies

October 2, 2012
·
1 min read
Business

Third Rock Ventures Appoints Personalized Medicine Expert Felix W. Frueh, Ph.D., as Entrepreneur-in-Residence

October 2, 2012
·
1 min read